Conmed (CNMD) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.80% |
| Dec 31, 2025 | 5.83% |
| Sep 30, 2025 | 5.91% |
| Jun 30, 2025 | 6.20% |
| Mar 31, 2025 | 5.58% |
| Dec 31, 2024 | 5.37% |
| Sep 30, 2024 | 5.66% |
| Jun 30, 2024 | 5.37% |
| Mar 31, 2024 | 5.57% |
| Dec 31, 2023 | 10.93% |
| Sep 30, 2023 | 11.28% |
| Jun 30, 2023 | 11.24% |
| Mar 31, 2023 | 11.44% |
| Dec 31, 2022 | 11.09% |
| Sep 30, 2022 | 10.98% |
| Jun 30, 2022 | 9.19% |
| Mar 31, 2022 | 6.10% |
| Dec 31, 2021 | 5.85% |
| Sep 30, 2021 | 5.68% |
| Jun 30, 2021 | 5.65% |
| Mar 31, 2021 | 5.40% |
| Dec 31, 2020 | 9.72% |
| Sep 30, 2020 | 9.76% |
| Jun 30, 2020 | 9.61% |
| Mar 31, 2020 | 9.99% |
| Dec 31, 2019 | 10.08% |
| Sep 30, 2019 | 9.65% |
| Jun 30, 2019 | 9.90% |
| Mar 31, 2019 | 10.21% |
| Dec 31, 2018 | 4.66% |
| Sep 30, 2018 | 4.69% |
| Jun 30, 2018 | 4.72% |
| Mar 31, 2018 | 4.51% |
| Dec 31, 2017 | 4.71% |
| Sep 30, 2017 | 4.57% |
| Jun 30, 2017 | 4.70% |
| Mar 31, 2017 | 4.29% |
| Dec 31, 2016 | 7.27% |
| Sep 30, 2016 | 5.90% |
| Jun 30, 2016 | 6.01% |
| Dec 31, 2015 | 2.25% |